News
🇪🇺 EMA Page 14Latest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 157–168 of 353 articles
Purdue Pharma Shutdown: $7.4B Deal Ends OxyContin Maker's Operations
Pain · 5 min
James ParkEULAR 2026: Immutep's IMP761 Phase I Data Preview
immunology · 3 min
Robert KimNovelty Nobility Expands AGC Biologics Partnership for Bispecific Antibody Manufacturing
2 min
James ParkSmartee Denti-Technology Advances Mandibular Repositioning Technology at European Aligner Society Congress 2026
2 min
Robert KimSwiss Biotech Day 2026: AI, Oncology, Microbiome Highlights
biotech · 3 min
Robert KimPurdue Pharma Dissolution Approved: What It Means for Opioid Crisis
Pain · 6 min
James ParkAuvelity FDA Approval: New Hope for MDD Patients
FDA · Major Depressive Disorder (MDD) · 6 min
Robert KimSynbioTech Unveils Microbiome-Based Platform for Women's Healthy Aging at Vitafoods Europe 2026
2 min
James ParkCuraleaf Appoints Torsten Greif to Board as European Medical Cannabis Market Expands
2 min
Robert KimPharmaceutical Manufacturing Software Market to Reach $7.87 Billion by 2030, Driven by 15.8% CAGR Growth
2 min
James ParkGoodRx Offers Ozempic Pill Access for Type 2 Diabetes Patients at $149 Monthly
2 min
Robert KimPlozasiran TGA Approval in Australia for FCS Patients
TGA · Familial Chylomicronemia Syndrome (FCS) · 5 min
Robert KimPopular topics
- Drug Approvals 1,138 articles
- Clinical Trials 652 articles
- Regulatory Updates 695 articles
- Press Releases 443 articles
- Oncology 456 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 143 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways